Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from HBM Holdings Ltd. ( (HK:2142) ) is now available.
HBM Holdings Ltd. announced that it has received an upfront payment from Windward Bio AG as part of an exclusive license agreement for HBM9378/SKB378. This payment, which includes both cash and equity interest, is expected to strengthen the company’s cash reserves, potentially enhancing its operational capabilities and market positioning.
More about HBM Holdings Ltd.
HBM Holdings Ltd. is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. Its primary focus is on the development and commercialization of innovative therapeutics, with a market focus on advancing biopharmaceutical solutions.
YTD Price Performance: 194.09%
Average Trading Volume: 6,962,549
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$4.13B
For detailed information about 2142 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue